Refine by
Medication Monitoring Articles & Analysis
62 news found
Medicalgorithmics a Warsaw Stock Exchange listed medical technology company, is boosting its sales capabilities in North America with appointment of James Landis as the new Vice President of Sales and Business Development for North America. ...
This enables clinicians to identify stable patients that may be candidates for early discharge, potentially reducing hospital stays while providing medical grade monitoring in the convenience and comfort of a patient’s home. ...
American Medical Device Summit: Location: Westin Chicago Lombard, Chicago, Illinois Format: Panel Discussion “The Evolving Role of Medical Devices in Delivering At-Home Patient Care” Date: Wednesday, October 19th at 4:20 p.m. – 4:55 p.m. CST The American Medical Device Summit provides insights and strategies to enhance ...
Bioflux®, Biotricity’s high-precision, single-unit mobile cardiac telemetry device that provides real-time monitoring and transmission of the patient’s ECG information, has captured billions of heartbeats to date, monitored in real-time by Bioflux’s built in algorithms, certified cardiac technicians and benchmarked by Artificial Intelligence ...
Introduces medical radar monitoring and imaging technology (ReDS™) to Indian patients for the first time Addresses an unmet medical need for over 8 million patients across the country Terumo India, the Indian arm of Terumo Corporation (TSE: 4543), a global leader in medical technology, today announced that it has ...
Hospitals treating COVID-19 patients are looking to use the radar-based technology, previously used in heart-failure patients, to monitor lungs of coronavirus patients. Sensible Medical has recently received urgent requests from hospitals around the world for its ReDS monitors systems to improve monitoring, treatment and ...
(NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced that it will be carrying out an NIH-sponsored Phase I study of Bioflux-AI, Biotricity’s innovative artificial intelligence-driven (‘AI’) system of real-time monitoring and prediction technology, ...
Adults between the ages of 18 and 60 years with morbid obesity (BMI of > 40) or severe obesity (BMI of > 35) with at least one complication (diabetes, hypertension, sleep apnea syndrome, joint disorders) People who have already tried to lose weight without success despite receiving specialized medical care for several months (dietary monitoring, physical ...
Biobeat is thrilled to be part of "TGH at Home", an innovative Hospital-at-Home program by Tampa General Hospital. With its wireless chest-monitors, Biobeat will provide Remote Patient Monitoring (RPM) for the patients in the program, enabling expert care and innovative technology, focusing on the needs of the patient. Using Biobeat’s platform, the "TGH at Home" care team of doctors and ...
Biobeat is excited to join forces with Medidata Solutions and be part of the Sensor Cloud Network. By using Biobeat’s medical-grade wearables we are able to enhance clinical trials with vital signs collection to generate real-world evidence remotely and conveniently from the patient’s home. Our platform supports decentralized clinical trials and significantly reduces the logistics ...
Biobeat is further advancing in the Belgian market! We proudly announce our newest partner M-ighty in the EU market to promote the Biobeat system in Belgium. Both companies aim to improve clinical patient care and remote patient monitoring, as well as patient deterioration ...
“The T1D Consortium works to accelerate the process to develop these therapies, a goal that can only be achieved through rich collaboration between scientists, clinicians, patients, regulators and key industry members, such as Diamyd Medical. The data and expertise Diamyd Medical has shared with C-Path has been invaluable and we are thrilled for Diamyd ...
‘ATP-C70’, wearable ECG monitor of ATsens starts prescribing at Sejong Chungnam National University Hospital. It’s an extension of the smart ward platform business and is introduced into Korea's first smart outpatient treatment program. It will support accurate vital sign measurement and customized diagnosis of arrhythmia patients through AT Patch, which can measure ECG for ...
(NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, will officially launch the commercial sales of its FDA cleared, wireless wearable cardiac monitoring device, Biotres, in April 2022. The product has been available for pre-orders to physicians, medical offices, ...
Transformative closed-loop technology senses the spinal cord’s response to stimulation and instantaneously adjusts therapy to sustain durable, optimized treatment Long-term results published in two premier clinical journals show clinically meaningful improvements in pain relief, physical and emotional functioning, sleep quality, and health-related quality of life Saluda ...
Heier, MD, one of the study's principal investigators and director of the retinal service and retinal research at Ophthalmic Consultants of Boston. "Remote monitoring services can help retina specialists extend care to patients' homes and provide timely treatment in the office as needed." ...
The Company believes that its wireless, wearable Biotres device offers a secondary product for doctors and hospitals to meet their patients’ cardiac monitoring needs and addresses the $5.7 billion cardiac arrhythmia monitoring devices market. The conventional one-lead patch Holter monitor has been the standard of care for cardiac ...
Food and Drug Administration (FDA) for its Biotres Cardiac Monitoring Device, a three lead device for ECG and arrhythmia monitoring that is intended for lower risk patients. ...
Saluda Medical Pty Limited (“Saluda Medical”), a global company on a mission to revolutionize the field of neuromodulation with an emerging portfolio of therapies driven by advanced closed-loop technologies designed to treat debilitating neurological disorders, today announced long-term results of its double-blind Level 1 EVOKE randomized controlled ...
Differentiating between a Parkinsonian tremor and other tremor disorders is challenging.1 Early and correct differential diagnosis is crucial to quickly provide access to best medical treatments and other forms of support. In a community-based study of the accuracy of PD diagnosis, essential tremor (ET), the most common movement disorder, accounted for 48% of the misdiagnoses.2 ...